ferric gluconate: Clinical Trials

5 trials of ferric gluconate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Not yet recruiting 1, Unknown 1
Phase 21Completed 1

Follow ferric gluconate: new trials by email Literature Review of ferric gluconate trials Research Report on ferric gluconate

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer
IV iron - Anaemia in Ovarian Carcinoma
Phase 3Not yet recruitingUniversity of Saskatchewan2002024-02-292024-02-08
Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
Sucrosomial iron, Ferric Gluconate, Ferric carboxymaltose - Iron Deficiency Anemia, Inflammatory Bowel Diseases
Phase 3UnknownFondazione IRCCS Policlinico San Matteo di Pavia3002020-01-012020-10-19
Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
Ferric Carboxymaltose, Standard Medical Care (SMC) - Anemia
Phase 3CompletedAmerican Regent, Inc.7352008-06-012018-02-20
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose - Anemia, Leukemia
Phase 3CompletedMayo Clinic5022006-01-012011-05-17
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Sodium Ferric Gluconate Complex, Oral Iron - Iron Deficiency Anemia
Phase 2 / Phase 3CompletedWatson Pharmaceuticals1462003-12-012013-07-08

Conditions studied

Anemia (4)  ·  Anemia, Iron-Deficiency (2)  ·  Burkitt Lymphoma (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Inflammatory Bowel Diseases (1)  ·  Iron Deficiencies (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)

Sponsors

American Regent, Inc. (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Mayo Clinic (1)  ·  University of Saskatchewan (1)  ·  Watson Pharmaceuticals (1)

Countries

United States (3)  ·  Canada (2)  ·  Bulgaria (1)  ·  Croatia (1)  ·  India (1)  ·  Italy (1)  ·  Mexico (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Antonio Di Sabatino, MD (1)  ·  Charles L. Loprinzi, MD (1)  ·  Gary Hoel, RPh, PhD (1)  ·  Maryam Al-Hayki (1)  ·  Tom R. Fitch, M.D. (1)

NIH funding

P30CA015083 (1)